Publications by authors named "Daniel Drazan"

Claim this Profile
C
Comparative assessment of immunogenicity and safety of recombinant influenza vaccine in children, adolescents, and adults: results from a phase 3, immunobridging, open-label, non-randomised study.
Pedro M Folegatti, Stephanie Pepin, Cynthia Tabar, Katherine Fries, Oxana Talanova, Daniel Drazan

Lancet Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial.
Terry Nolan, Chiranjiwi Bhusal, Jiří Beran, Mark Bloch, Benhur Sirvan Cetin

Lancet Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose.
James Peterson, Daniel Drazan, Beth Moughan, Jason D Maguire, Lefteris Zolotas

Vaccine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.
Terry Nolan, Chiranjiwi Bhusal, Jiří Beran, Mark Bloch, Benhur S Cetin

Open Forum Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial.
James Peterson, Daniel Drazan, Hanna Czajka, Jason Maguire, Jean-Louis Pregaldien

Lancet Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adults.
Daniel Drazan, Hanna Czajka, Jason D Maguire, Jean-Louis Pregaldien, Roger Maansson

Vaccine· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of Investigational MenABCWY Vaccine and of 4CMenB and MenACWY Vaccines Administered Concomitantly or Alone: a Phase 2 Randomized Study of Adolescents and Young Adults.
Jiří Beran, Daniel Dražan, Igwebuike Enweonye, Chiranjiwi Bhusal, Daniela Toneatto

mSphere· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Readers' responses to the webcast video editorial entitled "caution--lab test ordering trouble ahead".
Daniel Drazan

MedGenMed· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis